Related Experiment Video
Updated: Aug 29, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is
Brian S Knipp1, Gorav Ailawadi, John W Ford
1Jobst Vascular Research Laboratories, Section of Vascular Surgery, Ann Arbor, Michigan 48109-0329, USA. riversu@umich.edu
Objective:
To determine the mechanism underlying increased expression and activity of matrix metalloproteinase 9 (MMP-9) by rat aortic smooth muscle cells (RA-SMC) after inhibition of inducible nitric oxide synthase (iNOS).
Methods And Results:
Treatment of interleukin-1beta-stimulated RA-SMC with aminoguanidine led to an increase of 96% in MMP-9 activity (P = 0.003) by gelatin zymography, a 40% increase in pro-MMP-9 protein (P = 0.018) by Western blot, and a 155% increase in MMP-9 mRNA (P = 0.06) by reverse transcription polymerase chain reaction. Aminoguanidine also caused a 26% decrease in cytosolic IkappaB levels (P = 0.014) by Western blot, as well as a 97% increase in nuclear factor-kappaB binding and a 216% increase in activator protein-1 binding as measured by electrophoretic mobility shift assay. No significant changes were noted in MMP-2 or TIMP-1 expression, protein levels, or activity after aminoguanidine administration.
Conclusions:
MMP-9 expression and activity is increased in cytokine stimulated RA-SMCs after iNOS inhibition, coincident with activation of the nuclear factor-kappaB and activator protein-1 pathways. We speculate that local derangements in iNOS may favor MMP-9-dependent vessel wall damage in vivo via an inflammatory cascade mechanism.
Insights
Inhibiting inducible nitric oxide synthase (iNOS) in rat aortic smooth muscle cells increases matrix metalloproteinase 9 (MMP-9) expression and activity. This occurs via activation of nuclear factor-kappaB and activator protein-1 pathways, potentially leading to vessel wall damage.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Biochemistry
Background:
- Inducible nitric oxide synthase (iNOS) plays a role in vascular homeostasis.
- Matrix metalloproteinase 9 (MMP-9) is implicated in vascular remodeling and disease.
- Understanding the interplay between iNOS and MMP-9 is crucial for cardiovascular research.
Purpose of the Study:
- To elucidate the mechanism by which inhibiting iNOS in rat aortic smooth muscle cells (RA-SMC) leads to increased MMP-9 expression and activity.
- To investigate the downstream signaling pathways involved in this process.
Main Methods:
- Rat aortic smooth muscle cells (RA-SMC) were stimulated with interleukin-1beta.
- iNOS was inhibited using aminoguanidine.
- MMP-9 activity, protein, and mRNA levels were assessed using gelatin zymography, Western blot, and RT-PCR, respectively.
- NF-kappaB and AP-1 activation were measured by electrophoretic mobility shift assay.
Main Results:
- Aminoguanidine treatment significantly increased MMP-9 activity, pro-MMP-9 protein, and MMP-9 mRNA levels in stimulated RA-SMC.
- Inhibition of iNOS led to decreased cytosolic IkappaB levels, indicating activation of the NF-kappaB pathway.
- NF-kappaB and AP-1 binding activity were significantly increased following aminoguanidine administration.
- No significant changes in MMP-2 or TIMP-1 were observed.
Conclusions:
- iNOS inhibition in cytokine-stimulated RA-SMCs upregulates MMP-9 expression and activity.
- This upregulation is associated with the activation of NF-kappaB and AP-1 signaling pathways.
- Disruptions in iNOS function may promote MMP-9-mediated vascular damage through inflammatory cascades.
More Related Videos
Related Concept Videos
Nitric Oxide Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...
MAPK Signaling Cascades
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway

